Overview
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
Status:
Unknown status
Unknown status
Trial end date:
2009-06-01
2009-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is to compare the safety and efficacy of two drops used to lower eye pressure when given prior to a glaucoma laser procedure.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Walter Reed Army Medical CenterTreatments:
Apraclonidine
Brimonidine Tartrate
Criteria
Inclusion Criteria:- male or female, at least 18 years of age
- Open Angle Glaucoma with inadequate intraocular pressure (IOP) control or evidence of
progression (based on optic nerve head appearance and/or visual field changes) despite
current medical therapy
- Ocular Hypertension requiring lowering of IOP
- ability to understand and provide informed consent to participate in this study and
willingness to follow study instructions and likely to complete all required visits
Exclusion Criteria:
- inability to understand and provide informed consent to participate in this study
- inability/unwillingness to follow study instructions and complete all required visits
- Documented allergy to either brimonidine or iopidine
- Angle Closure Glaucoma
- Congenital/Juvenile Glaucoma
- Neovascular Glaucoma
- Active uveitis